The risk of complex hyperplasia of the endometrium with atypia progressing to malignancy in a postmenopausal woman is about:
First, I remember that endometrial hyperplasia can be classified into simple, complex, and with or without atypia. The presence of atypia is a key factor here. Complex hyperplasia without atypia has a lower risk of progressing to cancer compared to when there's atypia involved.
From what I've studied, the risk of malignancy in complex hyperplasia with atypia is significantly higher. I think the numbers are around 25-30% for complex without atypia and up to 50-70% for complex with atypia. But I need to confirm these percentages.
Wait, postmenopausal women are at higher risk because they might have prolonged estrogen exposure without progesterone, leading to endometrial changes. The risk for complex atypical hyperplasia converting to cancer is high, maybe around 50-70% over time if not treated. The question asks for the risk, so the answer options might be percentages like 50%, 70%, 10%, etc. Since the correct answer is not given, I need to deduce based on standard references.
In medical textbooks, complex hyperplasia with atypia is considered a precursor lesion with a high risk of progressing to endometrial adenocarcinoma. The exact risk is often cited as approximately 50-70%. So if the options include 70%, that's likely the correct answer.
Now, for the wrong options: simple hyperplasia without atypia has a low risk, maybe around 5%. Complex without atypia is higher, maybe 10-15%. So if the options have 5%, 10%, 70%, then 70% is correct.
Clinical pearls: Atypia is a critical factor in determining malignancy risk. Postmenopausal women with abnormal uterine bleeding should undergo endometrial biopsy to assess for hyperplasia with atypia. Treatment often involves progestin therapy or hysterectomy to prevent cancer.
**Core Concept**
This question assesses knowledge of endometrial hyperplasia risk stratification. Complex hyperplasia with atypia (also termed *atypical hyperplasia*) is a high-grade precursor lesion for endometrial adenocarcinoma, driven by unopposed estrogen stimulation. Postmenopausal women are particularly vulnerable due to hormonal imbalances.
**Why the Correct Answer is Right**
Complex hyperplasia with atypia has a **50-70% risk of progressing to malignancy** if left untreated. This is due to clonal genetic abnormalities (e.g., PTEN mutations, p53 alterations) that drive malignant transformation. Postmenopausal women with this condition require prompt intervention (e.g., progestin therapy or hysterectomy) to prevent endometrial cancer.
**Why Each Wrong Option is Incorrect**
**Option A (5%):** Simple hyperplasia without atypia has a low (5